Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis

Endocrine Journal

Volumn 58, Issue 5, 2011, Pages 349-354

  Türemen, Esat Erdem ^a   Çetinarslan, Berrin ^a   Şahin, Tayfun ^a   Cantürk, Zeynep ^a   Tarkun, Ilhan ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Autoimmune thyroiditis; Endothelial dysfunction; Low grade chronic inflammation; Subclinical hypothyroidism

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; ARTERY DIAMETER; ARTERY ENDOTHELIUM; ARTICLE; ASYMPTOMATIC DISEASE; AUTOIMMUNE THYROIDITIS; BLOOD VESSEL REACTIVITY; BODY MASS; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; THYROID FUNCTION TEST; THYROXINE BLOOD LEVEL; VASCULAR ENDOTHELIUM; WAIST CIRCUMFERENCE;

ADULT; AGED; BRACHIAL ARTERY; C-REACTIVE PROTEIN; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPOTHYROIDISM; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; NITROGLYCERIN; THYROIDITIS, AUTOIMMUNE; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR RESISTANCE; VASODILATION;

EID: 79958070445     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K10E-333     Document Type: Article

References (21)

1. Quyyumi A (1998) Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 105: 32S-39S.
2. Ross, R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126.
3. Coretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfeld J, Drexler H, Gerhard- Herman M, Herrington D, Vallance P, Vita J & Vogel R (2002) Guidelines for the ultrasound assessment of endothelium-dependent flowmediated vasodila-tion of the brachial artery. A Report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39: 257-265.
4. Laufs U, La Fata V, Plutzky J, Liao JK (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97: 1129-1135.
5. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP (1999) Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimeth-ylaminohydrolase. Circulation 99:3092-3095.
6. Efstathiadou Z, Bitsis S, Milionis HJ, Kukuvitis A, Bairaktari ET, Elisaf MS, Tsatsoulis A (2001) A lipid profle in subclinical hypothyroidism: is L-thyroxine substitution benefcial? Eur J Endocrinol 145: 705-710.
7. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Salvetti A, Ferrannini E, Monzani F 2003 Impaired endothelium-dependent vasodilatation in sub-clinical hypothyroidism: benefcial effect of levothyrox-ine therapy. J Clin Endocrinol Metab 88: 3731-3737.
8. Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M, Donald AE, Palacios M, Griffn GE, Deanfeld JE, MacAllister RJ, Vallance P (2000) Acute systemic inflammation impairs endothelium-de-pendent dilatation in humans. Circulation 102: 994-999.
9. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM (2000) Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102: 1000-1006.
10. Kharbanda RK, Walton B, Allen M, Klein N, Hingorani AD, MacAllister RJ, Vallance P (2002) Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin. Circulation 105: 2600-2604.
11. Schuett H, Luchtefeld M, Grothusen C, Grote K, Schieffer B (2009) How much is too much? Interleukin-6 and its signalling in atherosclerosis. Thromb Haemost 102: 215-222.
12. Figueroa-Vega N, Alfonso-Pérez M, Benedicto I, Sánchez-Madrid F, González-Amaro R, Marazuela M (2010) Increased circulating pro-inflammatory cytok-ines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metab 95: 953-962.
13. Papanas N, Papazoglou D, Papatheodorou K, Antonoglou C, Kotsiou S, Maltezos E (2006) Thyroxine replacement dose in patients with Hashimoto disease:a potential role for interleukin-6. Cytokine 35: 166-70.
14. Matsuno H, Yudoh K, Katayama R, Nakazawa F, Uzuki M, Sawai T, Yonezawa T, Saeki Y, Panayi GS, Pitzalis C, Kimura T et al. (2002) The role of TNF-alpha in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/ SCID mouse chimera. Rheumatology (Oxford) 41: 329-337.
15. Scheurich P, Thoma B, Ucer U, Pfzenmaier K (1987) Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J Immunol 138: 1786-1790.
16. Aust G, Heuer M, Laue S, Lehmann I, Hofmann A, Heldin NE, Scherbaum WA (1996) Expression of tumour necrosis factor-alpha (TNF-alpha) mRNA and protein in pathological thyroid tissue and carcinoma cell lines. Clin Exp Immunol 105: 148-154.
17. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3: 745-756.
18. Muppidi, J. R., Tschopp, J., Siegel, R. M. (2004) Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 21: 461-465.
19. Chen K, Wei Y, Sharp GC, Braley-Mullen H Decreasing (2007) TNF-alpha results in less fbrosis and earlier resolution of granulomatous experimental autoimmune thyroiditis. J Leukoc Biol 81: 306-314.
20. Christ-Crain M, Meier C, Guglielmetti M Huber PR, Riesen W, Staub JJ, Müller B (2003) Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 166: 379-386.
21. Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J (2004) Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride and predicts cardiovascular disease in males below 50 years. Clin Endocrinol 61: 232-238.